Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mary Eapen, MD
Center for International Blood and Marrow Transplant Research
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Benioff Children'S Hospital at Oakland
Oakland, California, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- University of Florida Gainsville
Gainesville, Florida, United States
- Foundation for Sickle Cell Research/florida Sickle Inc.
Hollywood, Florida, United States
- University of Miami
Miami, Florida, United States
- Children'S Healthcare of Atlanta
Atlanta, Georgia, United States
- Emory University
Atlanta, Georgia, United States
- Grady Memorial Hospital
Atlanta, Georgia, United States
- Augusta University Medical Center
Augusta, Georgia, United States
- University of Iowa
Iowa City, Iowa, United States
- Children'S Hospital of New Orleans
New Orleans, Louisiana, United States
- Boston University
Boston, Massachusetts, United States
- Dana Farber Cancer Institute/brigham & Women'S Hospital
Boston, Massachusetts, United States
- Dana Farber Cancer Institute/massachusetts General Hospital
Boston, Massachusetts, United States
- Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
- Washington University/st. Louis Children'S Hospital
St Louis, Missouri, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Newark Beth Israel Medical Center
Newark, New Jersey, United States
- New York Presbyterian Brooklyn Methodist Hospital
Brooklyn, New York, United States
- Cohen Children'S Medical Center
New Hyde Park, New York, United States
- Icahn School of Medicine at Mount Sinai
New York, New York, United States
- Weill Cornell Medical College
New York, New York, United States
- Montefiore Medical Center/albert Einstein School of Medicine
The Bronx, New York, United States
- University of North Carolina Hospital at Chapel Hill
Chapel Hill, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Ohio State University
Columbus, Ohio, United States
- University of Oklahoma
Oklahoma City, Oklahoma, United States
- Oregon Health Sciences University
Portland, Oregon, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Baylor College of Medicine/the Methodist Hospital
Houston, Texas, United States
- University of Texas Health Sciences Center
Houston, Texas, United States
- University of Texas/md Anderson Crc
Houston, Texas, United States
- University of Virginia
Charlottesville, Virginia, United States
- Virginia Commonwealth University
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Mar 2017
- Primary completion
- 2 May 2023
- Completion
- 2 Aug 2023
- Last update posted
- 18 Apr 2025
- Registered enrollment
- 138
- Registry id
- NCT02766465
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.